The Effect of Subcutaneous Deferoxamine on the Cardiac Profile of Thalassemia Major: A Five‐Year Study
- 1 June 1985
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 445 (1) , 282-292
- https://doi.org/10.1111/j.1749-6632.1985.tb17198.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balanceThe Journal of Pediatrics, 1981
- LONGITUDINAL STUDY OF CARDIAC FUNCTION IN THALASSEMIA MAJOR *Annals of the New York Academy of Sciences, 1980
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Iron in the heartThe American Journal of Medicine, 1971
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971
- Ultrasonic Cardiac Echography for Determining Stroke Volume and Valvular RegurgitationCirculation, 1970
- Histochemical Studies of the Myocardium and Conduction System in Acquired Iron-Storage DiseaseCirculation, 1967
- Late Cardiac Complications of Chronic, Severe, Refractory Anemia with HemochromatosisCirculation, 1964
- Cardiac complications of chronic, severe, refractory anemia with hemochromatosisThe Journal of Pediatrics, 1961